Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat AL McCormack, M Thiruchelvam, AB Manning-Bog, C Thiffault, ... Neurobiology of disease 10 (2), 119-127, 2002 | 1059 | 2002 |
The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice: paraquat and α-synuclein AB Manning-Bog, AL McCormack, J Li, VN Uversky, AL Fink, DA Di Monte Journal of Biological Chemistry 277 (3), 1641-1644, 2002 | 891 | 2002 |
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease D Kaur, F Yantiri, S Rajagopalan, J Kumar, JQ Mo, R Boonplueang, ... Neuron 37 (6), 899-909, 2003 | 765 | 2003 |
CSF hypocretin/orexin levels in narcolepsy and other neurological conditions B Ripley, S Overeem, N Fujiki, S Nevsimalova, M Uchino, J Yesavage, ... Neurology 57 (12), 2253-2258, 2001 | 495 | 2001 |
Alterations in intracellular thiol homeostasis during the metabolism of menadione by isolated rat hepatocytes D Di Monte, D Ross, G Bellomo, L Eklöw, S Orrenius Archives of Biochemistry and Biophysics 235 (2), 334-342, 1984 | 495 | 1984 |
The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? DA Di Monte The Lancet Neurology 2 (9), 531-538, 2003 | 464 | 2003 |
Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration WM Caudle, JR Richardson, MZ Wang, TN Taylor, TS Guillot, ... Journal of Neuroscience 27 (30), 8138-8148, 2007 | 446 | 2007 |
Menadione-induced cytotoxicity is associated with protein thiol oxidation and alteration in intracellular Ca2+ homeostasis D Di Monte, G Bellomo, H Thor, P Nicotera, S Orrenius Archives of Biochemistry and Biophysics 235 (2), 343-350, 1984 | 428 | 1984 |
Nuclear localization of α-synuclein and its interaction with histones J Goers, AB Manning-Bog, AL McCormack, IS Millett, S Doniach, ... Biochemistry 42 (28), 8465-8471, 2003 | 416 | 2003 |
Lysosomal degradation of α-synuclein in vivo SK Mak, AL McCormack, AB Manning-Boğ, AM Cuervo, DA Di Monte Journal of Biological Chemistry 285 (18), 13621-13629, 2010 | 414 | 2010 |
Behavioral and neurochemical effects of wild-type and mutated human α-synuclein in transgenic mice EK Richfield, MJ Thiruchelvam, DA Cory-Slechta, C Wuertzer, ... Experimental neurology 175 (1), 35-48, 2002 | 363 | 2002 |
Lack of nigral pathology in transgenic mice expressing human α-synuclein driven by the tyrosine hydroxylase promoter Y Matsuoka, M Vila, S Lincoln, A McCormack, M Picciano, J LaFrancois, ... Neurobiology of disease 8 (3), 535-539, 2001 | 359 | 2001 |
Age‐related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype M Thiruchelvam, A McCormack, EK Richfield, RB Baggs, AW Tank, ... European Journal of Neuroscience 18 (3), 589-600, 2003 | 357 | 2003 |
Environmental factors in Parkinson’s disease DA Di Monte, M Lavasani, AB Manning-Bog Neurotoxicology 23 (4-5), 487-502, 2002 | 354 | 2002 |
Role of oxidative stress in paraquat‐induced dopaminergic cell degeneration AL McCormack, JG Atienza, LC Johnston, JK Andersen, S Vu, ... Journal of neurochemistry 93 (4), 1030-1037, 2005 | 329 | 2005 |
Formation and reduction of glutathione-protein mixed disulfides during oxidative stress: A study with isolated hepatocytes and menadione (2-methyl-1, 4-naphthoquinone) G Bellomo, F Mirabelli, D DiMonte, P Richelmi, H Thor, C Orrenius, ... Biochemical pharmacology 36 (8), 1313-1320, 1987 | 308 | 1987 |
Dopamine and L‐dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease JIE Li, MIN Zhu, AB Manning-Bog, DA Di Monte, AL Fink The FASEB journal 18 (9), 962-964, 2004 | 303 | 2004 |
MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology JK Mallajosyula, D Kaur, SJ Chinta, S Rajagopalan, A Rane, DG Nicholls, ... PloS one 3 (2), e1616, 2008 | 300 | 2008 |
Caudo‐rostral brain spreading of α‐synuclein through vagal connections A Ulusoy, R Rusconi, BI Pérez‐Revuelta, RE Musgrove, M Helwig, ... EMBO molecular medicine 5 (7), 1119-1127, 2013 | 297 | 2013 |
Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration MG Purisai, AL McCormack, S Cumine, J Li, MZ Isla, DA Di Monte Neurobiology of disease 25 (2), 392-400, 2007 | 296 | 2007 |